Department of Hematological Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Research Interests: pathogenesis of myeloid malignancies; immune model and immune treatment for hematological cancer.

Deputy Director of the Department of Hematology, Director of the Hematopoietic Stem Cell Transplantation Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Research Interests: hematopoietic stem cell transplantation (especially in adverse-risk AML/MDS, SAA, ALL); clinacal and translational research in infectious diseases in hematological diseases; research on erythropoiesis after hematopoietic stem cell transplantation).

Executive Director of Caring Cross, Gaithersburg, MD, USA.
Research Interests: gene therapy.

Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong, China.
Research Interests: stem cell transplantation; leukemia.

Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Research Interests: targeted therapy and immunotherapy for hematological malignancies such as multiple myeloma; lymphoma and leukemia; CAR-T cell therapy; diagnosis and treatment of rare plasma cell diseases (e.g., POEMS syndrome, amyloidosis).

Institute of Harbin Hematology and Oncology, The First Hospital of Harbin, Harbin, China.
Research Interests: clinical and translational study of hematology.

Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Shanxi, China.
Research Interests: immunotherapy for malignant hematologic diseases.

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Research Interests: pathogenesis and therapeutic strategies of drug-resistant and relapsed pediatric hematologic diseases; cellular immunotherapy.
